Vytorin Cuts Cardiac Risk in Chronic Kidney Disease - Internal Medicine News Digital Network Print
Internal Medicine News Digital NetworkHe presented the study results at the annual meeting of the American Society of Nephrology. Merck will seek Food and Drug Administration approval for

...